Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 5:15 p.m.
A driver accused of brandishing a weapon slammed into a patrol car in a police chase, according to the California Highway ...
Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile ...
A wind advisory for much of the Bay Area remained in effect Wednesday morning, and some areas were seeing damage from strong ...
Roy’s Redwoods is named for two brothers from Vermont, James and Thomas Roy, according to the Marin Journal. They received ...
His son, Jon Pettinelli, who has served as president since January 2019, will now be CEO and lead the firm’s daily activities. The firm also announced new partners Janice Fong, Allison Steele, Rick ...
Shares of Jasper Therapeutics, Inc. (Nasdaq: JSPR) plummeted over 40% following the release of data from its BEACON study of Briquilimab in Chronic Spontaneous Urticaria (CSU). Despite the company ...
New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...
Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...
There are currently ‘no plans’ for Warrington Borough Council to exit its investment in Redwood Bank, according to a report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback